Oliver Kepp
  • E-mail :[email]
  • Phone : 33142114516
  • Location : Villejuif, France
Last update 2019-11-22 18:37:31.757

Oliver Kepp PhD Molecular Biology

Course and current status

Since 2013 Direktor Cell Biology platform, Gustave Roussy Cancer Center, Villejuif, France

Since 2012 CR1, INSERM U1138 (Kroemerlab), Centre de Recherche Des Cordeliers, Paris, France

2011 INSERM PostDoctoral fellow, Gustave Roussy Cancer Center, Villejuif, France

2008-2010 EMBO fellow, INSERM U848 (Kroemerlab), Gustave Roussy Cancer Center, Villejuif, France

2007 Max Planck PostDoctoral fellow, Max Planck Insitute for Infection Biology, Berlin, Germany

2006 PhD Max Planck Insitute for Infection Biology, Humboldt University, Berlin, Germany

Scientific summary

Dr. Oliver Kepp, studied biology at the Humboldt University (Berlin, Germany) and obtained a PhD degree in molecular biology for his work on host cell apoptosis in Neisseria infection at the Max Planck Institute for Infection Biology (Berlin, Germany). Following he received a Max Planck postdoctoral research fellowship and in 2007 joined the INSERM team U848 directed by Guido Kroemer at the Gustave Roussy Cancer Center (Villejuif, France) as an EMBO postdoc fellow. He now is a tenured researcher at INSERM (Paris, France) and Co-director of the BioCell automation platform (Villejuif, France). He investigates several aspects of immunogenic cell death, focusing on systems biology approaches. Oliver published more than 200 scientific articles, is a member of several editorial boards, a co-founder of Samsara therapeutics and has recently been appointed as associated director of the European academy of tumor immunology.

Image d’exemple